Dr.ย Chee Keongย Toh
MBBS, MRCP (UK), FAMS (Medical Oncology)
Senior Medical Oncologist ยท Thoracic Oncology
corporate_fareCurie Oncology, Mount Elizabeth Novena Hospital, Singapore
Chee Keong Toh
MBBS, MRCP (UK), FAMS (Medical Oncology)
Dr. Chee Keong Toh is a senior Singapore-based medical oncologist who sub-specialises in thoracic oncology, with a particular focus on lung cancer, EGFR-driven non-small cell lung cancer and thymic tumours. He also treats genitourinary cancers, including prostate, kidney, bladder and testicular cancer, as well as head and neck cancers.
Dr. Toh worked at the National Cancer Centre Singapore for the majority of his career, where he led the Lung Cancer Consortium project that coordinated lung cancer research across Singapore. He also spent three years as Director of Clinical Research at Raffles Cancer Centre before moving to Curie Oncology, where he currently practises, with consultations at Mount Elizabeth Novena Hospital. His clinical and research work has centred on lung cancer in Asian patients, including never-smokers, a group in whom EGFR mutations and targeted therapy have significantly changed treatment outcomes. He was part of the team awarded a National Medical Research Council Large Collaborative Grant for next-generation clinical trials in lung cancer, and contributed to Singapore Cancer Network guideline development for lung, kidney, prostate and bladder cancers.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Toh, subject to hospital availability and case acceptance.
Why Consider Dr. Chee Keong Toh?
Dr. Toh combines decades of thoracic oncology practice with a strong lung cancer research record, making him well suited to complex and molecularly driven lung cancer cases.
Areas of Specialization
Thoracic-focused medical oncology with genitourinary and head & neck expertise
Dr. Toh's practice centres on cancers of the chest, supported by molecular testing and systemic therapy, alongside genitourinary and head and neck oncology.
Thoracic Oncology
Systemic management of lung cancer and rare thoracic tumours.
- arrow_rightNon-small cell lung cancer, including lung adenocarcinoma
- arrow_rightAdvanced and metastatic lung cancer
- arrow_rightLung cancer in never-smokers
- arrow_rightEGFR tyrosine kinase inhibitor therapy for suitable patients
- arrow_rightTreatment planning guided by molecular testing
- arrow_rightTreatment sequencing after progression on targeted therapy
- arrow_rightMedical oncology management of thymic tumours
- arrow_rightSystemic therapy planning for pleural malignancies such as mesothelioma
Genitourinary & Head and Neck Oncology
Medical oncology for urological and head and neck cancers.
- arrow_rightProstate, kidney, bladder and testicular cancers
- arrow_rightSystemic therapy and treatment planning
- arrow_rightMedical oncology input within a multidisciplinary plan
Procedures Performed
Clinical services and treatment approaches
Treatment choice depends on cancer type, stage, molecular markers, previous treatment, performance status and patient goals.
Systemic Cancer Treatment
Medical OncologyTreatment planning and administration of systemic therapy for thoracic and other cancers.
Targeted Therapy for Lung Cancer
Targeted TherapyMolecularly guided targeted treatment for eligible lung cancer patients.
Diagnostic & Staging Work-Up
DiagnosisMolecular and imaging-based assessment to guide treatment planning.
Second Opinion Consultations
Second OpinionIndependent review of diagnosis and treatment plan for thoracic and rare cancers.
Research & Publications
Lung cancer research leadership and peer-reviewed contributions
Dr. Toh has contributed to lung cancer research in Singapore, particularly in understanding lung cancer patterns among Asian patients and the role of targeted therapy.
A more detailed publication list may be available on request via CancerFax.
Education & Training
Dr. Toh trained at the National University of Singapore and completed overseas oncology training in the United States under Singapore's Health Manpower Development Programme.
Clinical Experience
Dr. Toh has more than 20 years of medical oncology experience across the National Cancer Centre Singapore, Raffles Cancer Centre and Curie Oncology.
Languages & International
Dr. Toh consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients.
CancerFax can coordinate professional medical interpreter support when required.
How CancerFax Helps You Access Dr. Chee Keong Toh
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Chee Keong Toh's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Chee Keong Toh's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Chee Keong Toh before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Chee Keong Toh's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Chee Keong Toh's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Chee Keong Toh's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Chee Keong Toh
Yes. Dr. Toh is a medical oncologist who sub-specialises in thoracic oncology, including lung cancer and thymic tumours. He also treats genitourinary and head and neck cancers.
Yes. His clinical and research background is closely focused on EGFR-mutated non-small cell lung cancer, and his published work has examined the impact of EGFR tyrosine kinase inhibitors on lung cancer survival in Singapore.
Dr. Toh currently practises at Curie Oncology, with consultations at Mount Elizabeth Novena Hospital, Singapore. He worked at the National Cancer Centre Singapore for most of his career, where he led the Lung Cancer Consortium project.
Yes. Singapore is a major destination for international oncology care. CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Toh, subject to hospital availability and case acceptance.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case for submission, and coordinate the next steps with the hospital or doctor, subject to availability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, molecular profiling and treatment history. The final consultation format and availability depend on the doctor's institution.
Connect with Chee Keong Toh Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.